日發精機(002520.SZ):意大利MCM公司申請破產
格隆匯6月19日丨日發精機(002520.SZ)公佈,公司於2025年6月19日召開第八屆董事會第二十六次會議及第八屆監事會第二十三次會議,審議通過《關於意大利MCM公司申請破產的議案》,鑑於下屬全資子公司Machining Centers Manufacturing S.p.A(以下簡稱“意大利MCM公司”)因持續虧損,無法償還到期債務且已出現流動性不足的情形,為維護公司及公司股東的合法權益,公司董事會同意意大利MCM公司申請破產事項,同時授權意大利MCM公司經營管理層在法律法規允許的範圍內組織實施破產相關具體事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.